- Paediatrics (RCH) - Research Publications
Paediatrics (RCH) - Research Publications
Permanent URI for this collection
6 results
Filters
Reset filtersSettings
Statistics
Citations
Search Results
Now showing
1 - 6 of 6
-
ItemAmfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment optionsHodgkins, P ; Shaw, M ; Coghill, D ; Hechtman, L (SPRINGER, 2012-09)Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders among school-aged children. It is highly symptomatic and associated with significant impairment. This review examines the role of stimulant medications in the treatment of children and adolescents with ADHD. Published clinical studies that compared methylphenidate- and amfetamine-based stimulants in children and adolescents with ADHD support the therapeutic utility of stimulant treatments, and suggest robust efficacy and acceptable safety outcomes in groups treated with either stimulant. Evidence-based guidelines agree that each patient with ADHD is unique and individual treatment strategies that incorporate both drug and non-drug treatment options should be sought. In seeking to optimize individual response and outcomes to stimulant therapy, important considerations include the selection of stimulant class, the choice of long- or short-acting stimulant formulations, addressing effectively any emergent adverse effects and strategies aimed at enhancing adherence to dosing regimen and persistence on therapy.
-
ItemAvoiding the 'twilight zone': Recommendations for the transition of services from adolescence to adulthood for young people with ADHDYoung, S ; Murphy, CM ; Coghill, D (BMC, 2011-11-03)Attention deficit hyperactivity disorder (ADHD) is a common childhood disorder that frequently persists into adulthood. However, in the UK, there is a paucity of adult services available for the increasing number of young people with ADHD who are now graduating from child services. Furthermore, there is limited research investigating the transition of young people with ADHD from child to adult services and a lack of guidance on how to achieve this effectively. This paper reviews the difficulties of young people with ADHD and their families who are transitioning between services; we review transition from the child and adult health teams' perspectives and identify barriers to the transition process. We conclude with recommendations on how to develop transition services for young people with ADHD.
-
ItemMolecular genetics of attention-deficit/hyperactivity disorder: an overviewBanaschewski, T ; Becker, K ; Scherag, S ; Franke, B ; Coghill, D (SPRINGER, 2010-03)As heritability is high in attention-deficit/hyperactivity disorder (ADHD), genetic factors must play a significant role in the development and course of this disorder. In recent years a large number of studies on different candidate genes for ADHD have been published, most have focused on genes involved in the dopaminergic neurotransmission system, such as DRD4, DRD5, DAT1/SLC6A3, DBH, DDC. Genes associated with the noradrenergic (such as NET1/SLC6A2, ADRA2A, ADRA2C) and serotonergic systems (such as 5-HTT/SLC6A4, HTR1B, HTR2A, TPH2) have also received considerable interest. Additional candidate genes related to neurotransmission and neuronal plasticity that have been studied less intensively include SNAP25, CHRNA4, NMDA, BDNF, NGF, NTF3, NTF4/5, GDNF. This review article provides an overview of these candidate gene studies, and summarizes findings from recently published genome-wide association studies (GWAS). GWAS is a relatively new tool that enables the identification of new ADHD genes in a hypothesis-free manner. Although these latter studies could be improved and need to be replicated they are starting to implicate processes like neuronal migration and cell adhesion and cell division as potentially important in the aetiology of ADHD and have suggested several new directions for future ADHD genetics studies.
-
ItemThe quality of life of children with attention deficit/hyperactivity disorder: a systematic reviewDanckaerts, M ; Sonuga-Barke, EJS ; Banaschewski, T ; Buitelaar, J ; Doepfner, M ; Hollis, C ; Santosh, P ; Rothenberger, A ; Sergeant, J ; Steinhausen, H-C ; Taylor, E ; Zuddas, A ; Coghill, D (SPRINGER, 2010-02)Quality of life (QoL) describes an individual's subjective perception of their position in life as evidenced by their physical, psychological, and social functioning. QoL has become an increasingly important measure of outcome in child mental health clinical work and research. Here we provide a systematic review of QoL studies in children and young people with attention deficit hyperactivity disorder (ADHD) and address three main questions. (1) What is the impact of ADHD on QoL? (2) What are the relationships between ADHD symptoms, functional impairment and the mediators and moderators of QoL in ADHD? (3) Does the treatment of ADHD impact on QoL? Databases were systematically searched to identify research studies describing QoL in ADHD. Thirty six relevant articles were identified. Robust negative effects on QoL are reported by the parents of children with ADHD across a broad range of psycho-social, achievement and self evaluation domains. Children with ADHD rate their own QoL less negatively than their parents and do not always seeing themselves as functioning less well than healthy controls. ADHD has a comparable overall impact on QoL compared to other mental health conditions and severe physical disorders. Increased symptom level and impairment predicts poorer QoL. The presence of comorbid conditions or psychosocial stressors helps explain these effects. There is emerging evidence that QoL improves with effective treatment. In conclusion, ADHD seriously compromises QoL especially when seen from a parents' perspective. QoL outcomes should be included as a matter of course in future treatment studies.
-
ItemEuropean guidelines on managing adverse effects of medication for ADHDGraham, J ; Banaschewski, T ; Buitelaar, J ; Coghill, D ; Danckaerts, M ; Dittmann, RW ; Doepfner, M ; Hamilton, R ; Hollis, C ; Holtmann, M ; Hulpke-Wette, M ; Lecendreux, M ; Rosenthal, E ; Rothenberger, A ; Santosh, P ; Sergeant, J ; Simonoff, E ; Sonuga-Barke, EJS ; Wong, ICK ; Zuddas, A ; Steinhausen, H-C ; Taylor, E (SPRINGER, 2011-01)The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemporary-standard information about medications first licensed several decades ago, and signals of possible harm arising from more recently developed medications. These relate to both relatively minor adverse effects and extremely serious issues such as sudden cardiac death and suicidality. A guidelines group of the European Network for Hyperkinetic Disorders (EUNETHYDIS) has therefore reviewed the literature, recruited renowned clinical subspecialists and consulted as a group to examine these concerns. Some of the effects examined appeared to be minimal in impact or difficult to distinguish from risk to untreated populations. However, several areas require further study to allow a more precise understanding of these risks.
-
ItemEunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisationsSergeant, JA ; Banaschewski, T ; Buitelar, J ; Coghill, D ; Danckaerts, M ; Doepfner, M ; Rothenberger, A ; Santosh, P ; Sonuga-Barke, EJS ; Steinhausen, H-C ; Taylor, E ; Zuddas, A (SPRINGER, 2010-09)The Eunethydis ADHD Guidelines group set out here the ethical principles governing the relationship between the group and industry. The principles set out here are provided to ensure that this is both done and seen to be done. The impetus for these guidelines comes from within the Group and is linked to the recognition for the need for an open and transparent basis for Group-industry relations, especially in the light of the present concern that the pharmaceutical industry may be exerting a growing influence on the actions of researchers and clinicians in the ADHD field.